Literature DB >> 24656110

Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Kerry Wright1, Cynthia S Crowson2, Sherine E Gabriel3.   

Abstract

Rheumatic diseases are associated with an increased risk of cardiovascular (CV) mortality attributed to a higher incidence of heart failure (HF) and ischemic heart disease. Although traditional CV risk factors contribute to the increased incidence seen in this population, by themselves they do not account for the increased risk; in fact, obesity and hyperlipidemia may play a paradoxic role. Immune-mediated mechanisms and chronic inflammation likely play a role in the pathogenesis of CV disease in patients with rheumatic diseases. The usual clinical features of ischemic heart disease and HF are less likely to be seen in this patient population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Heart failure; Rheumatoid arthritis; Systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 24656110      PMCID: PMC3964373          DOI: 10.1016/j.hfc.2013.10.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  127 in total

1.  Autoantibodies and the risk of cardiovascular events.

Authors:  Kimberly P Liang; Hilal Maradit Kremers; Cynthia S Crowson; Melissa R Snyder; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

2.  Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.

Authors:  V P van Halm; M J L Peters; A E Voskuyl; M Boers; W F Lems; M Visser; C D A Stehouwer; A M W Spijkerman; J M Dekker; G Nijpels; R J Heine; L M Bouter; Y M Smulders; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2008-08-12       Impact factor: 19.103

3.  Cardiovascular morbidity in psoriatic arthritis.

Authors:  D D Gladman; M Ang; L Su; B D M Tom; C T Schentag; V T Farewell
Journal:  Ann Rheum Dis       Date:  2008-08-12       Impact factor: 19.103

4.  Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.

Authors:  Guillermo J Pons-Estel; Luis A González; Jie Zhang; Paula I Burgos; John D Reveille; Luis M Vilá; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-05-19       Impact factor: 7.580

5.  Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.

Authors:  Mike J L Peters; Vokko P van Halm; Alexandre E Voskuyl; Yvo M Smulders; Maarten Boers; Willem F Lems; Marjolein Visser; Coen D A Stehouwer; Jacqueline M Dekker; Giel Nijpels; Rob Heine; Ben A C Dijkmans; Michael T Nurmohamed
Journal:  Arthritis Rheum       Date:  2009-11-15

6.  Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.

Authors:  Young Hee Rho; Cecilia P Chung; Annette Oeser; Joseph Solus; Yu Asanuma; Tuulikki Sokka; Theodore Pincus; Paolo Raggi; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein
Journal:  Arthritis Rheum       Date:  2009-11-15

7.  Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.

Authors:  D McCarey; R D Sturrock
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

8.  Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

Authors:  A Elisabeth Hak; Elizabeth W Karlson; Diane Feskanich; Meir J Stampfer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-10-15

9.  No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.

Authors:  Marie E Holmqvist; Sara Wedrén; Lennart T H Jacobsson; Lars Klareskog; Fredrik Nyberg; Solbritt Rantapää-Dahlqvist; Lars Alfredsson; Johan Askling
Journal:  Arthritis Rheum       Date:  2009-10

10.  Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

Authors:  Srjdan Prodanovich; Robert S Kirsner; Jeffrey D Kravetz; Fangchao Ma; Lisa Martinez; Daniel G Federman
Journal:  Arch Dermatol       Date:  2009-06
View more
  18 in total

1.  Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Bent Ottesen; Lina Steinrud Mørch
Journal:  Ann Rheum Dis       Date:  2015-12-23       Impact factor: 19.103

2.  Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.

Authors:  John M Davis; Grace Lin; Jae K Oh; Cynthia S Crowson; Sara J Achenbach; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Int J Cardiol       Date:  2017-03-31       Impact factor: 4.164

3.  Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.

Authors:  Sameer Prasada; Adovich Rivera; Arvind Nishtala; Anna E Pawlowski; Arjun Sinha; Joshua D Bundy; Simran A Chadha; Faraz S Ahmad; Sadiya S Khan; Chad Achenbach; Frank J Palella; Rosalind Ramsey-Goldman; Yvonne C Lee; Jonathan I Silverberg; Babafemi O Taiwo; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  JACC Heart Fail       Date:  2020-04-08       Impact factor: 12.035

4.  Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography.

Authors:  Isabelle Amigues; Cesare Russo; Jon T Giles; Aylin Tugcu; Richard Weinberg; Sabahat Bokhari; Joan M Bathon
Journal:  Circ Cardiovasc Imaging       Date:  2019-12       Impact factor: 7.792

5.  Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; S Alvaro; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-07-19       Impact factor: 4.330

6.  Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis.

Authors:  M Robustillo-Villarino; J J Alegre-Sancho; E Rodilla-Sala; A Corrales; J Llorca; M A Gonzalez-Gay; P H Dessein
Journal:  Clin Rheumatol       Date:  2017-05-25       Impact factor: 2.980

7.  Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

Authors:  Maria Sakkou; Panagiotis Chouvardas; Lydia Ntari; Alejandro Prados; Kristin Moreth; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Maria C Denis; Niki Karagianni; George Kollias
Journal:  JCI Insight       Date:  2018-04-05

8.  Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis.

Authors:  Vanessa L Kronzer; Cynthia S Crowson; Jeffrey A Sparks; Elena Myasoedova; John M Davis
Journal:  Mayo Clin Proc       Date:  2019-11-20       Impact factor: 7.616

9.  Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis.

Authors:  Ashit Syngle; Inderjeet Verma; Pawan Krishan; Vijaita Syngle
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-03-15       Impact factor: 5.346

10.  Refocusing on the Primary Prevention of Heart Failure.

Authors:  Lua A Jafari; Rachel M Suen; Sadiya S Khan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.